Menu
Recruiting NCT06936280

Type 1 Diabetes and Diabetes Distress

No phase Interventional Diabetes Distress Diabetes Mellitus Type 1

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: ACTnow.
Who it may be relevant to
Registry conditions: Diabetes Distress, Diabetes Mellitus Type 1. Basic parameters: 18 years — 35 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Denmark
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Group-based Psychological Intervention for Emerging Adults With Type 1 Diabetes and Diabetes Distress

Overview

The goal of this clinical trial is to reduce diabetes distress in emerging adults (18-35 years) with type 1 diabetes and moderate-to-severe diabetes distress. The expectation is that a group-based psychological intervention (ACTnow) will not only reduce diabetes distress but also improve psychological well-being and glycemic outcomes. The intervention involves a multidisciplinary team, including nurses, psychologists, and physicians, and is designed in a format that can easily be integrated into future standard care. The main research questions are: * Does a group-based psychological intervention reduce diabetes distress? * Does a group-based psychological intervention improve psychological well-being and glycemic outcomes? Researchers will compare the group-based psychological intervention (arm 1) with a waitlist control group, which will receive the intervention after three months (arm 2). Participants will first attend a virtual screening interview with a psychologist or nurse to identify if they are eligible to participate in the study. After randomization, the intervention group receives six bi-weekly sessions, each lasting two hours, led by a psychologist and nurse. Each session includes a mindfulness exercise, a review of the previous session, a new topic, individual homework assignments, and a conclusion.

Interventions

  • Behavioral ACTnow
    The group-based psychological intervention consists of six bi-weekly sessions, each lasting two hours, with 6-10 participants per group, led by a psychologist and nurse. The intervention is based on Acceptance and Commitment Therapy (ACT), an evidence-based approach shown to be effective for chronic diseases, with additional elements from cognitive behavioral therapy and health education. It is manual-based, developed by experienced clinicians at SDCO, and includes tools from an existing diabet

Primary outcome measures

  • Change in diabetes distress score using T1-DDS [Time frame: from baseline to 3 months]
Secondary outcome measures (5)
  • Change in the T1-DDAS score [Time frame: from baseline to 3 months]
  • Change in AADQ score [Time frame: from baseline to 3 months]
  • Change in GAD-7 score [Time frame: from baseline to 3 months]
  • Change in HbA1c [Time frame: from baseline to 3 months]
  • Change in PHQ-9 score [Time frame: from baseline to 3 months]

Eligibility criteria

Inclusion criteria

  • Type 1 diabetes for at least 6 months
  • Age between 18 and 35
  • T1-DDS score ≥ 2, or T1-DDS subscale score ≥ 2
  • Treated in a diabetes clinic in the Region of Southern Denmark
  • Proficient in Danish

Exclusion criteria

  • Psychiatric diagnosis: diagnosed with substance abuse, alcohol abuse, psychosis, schizophrenia or any other psychiatric diagnosis that may compromise participation in the intervention
  • Cognitive disorders such as brain injury
  • Complex challenges best suited to individual treatment
  • Current therapeutic treatment for depression, anxiety or stress
  • Not stable medication for anxiety/depression for the past two months or planned change in medication for anxiety/depression during the project period

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Denmark · 3 centers
  • Esbjerg Hospital — Esbjerg
  • Odense University Hospital — Odense
  • Sønderborg Hospital — Sønderborg

Identifiers

NCT: NCT06936280 · 25/13117 · 25/13117

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗